PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
5 June 2018

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

Top Stories

Meeting the EU Serialization Deadline

Pharmaceutical companies and their contractors are reorganizing their manufacturing lines and logistics to ensure compliance with the serialization requirements, but many SMEs are struggling to meet the deadline.
/ read more /


Bayer Gets US Approval for $66-Billion Acquisition of Monsanto

Bayer received conditional approval from the Antitrust Division of the United States Department of Justice to acquire Monsanto in a deal worth $66 billion.
/ read more /

Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe
advertisement

advertisement

Industry News

Data Integrity Failures Found at China Facility

FDA sent a warning letter to Jilin Shulan Synthetic Pharmaceutical Co., Ltd. after an inspection found CGMP violations including a lack of data integrity.
/ read more /


WHO Vaccinates Against Ebola with Merck’s Experimental Vaccine

World Health Organization's Ebola ring vaccination uses Merck & Co.'s investigational rVSV-ZEBOV vaccine to protect high-risk communities in the Democratic Republic of the Congo from Ebola.
/ read more /


More Industry News
advertisement

Regulatory News

Novartis Gains EC Approval for Infliximab Biosimilar

The European Commission has approved Zessly (infliximab), a biosimilar to Johnson & Johnson's blockbuster Remicade (infliximab).
/ read more /


FDA Approves AstraZeneca’s Hyperkalemia Treatment

The new drug offers rapid and sustained control of patients’ potassium levels.
/ read more /


More Regulatory News

Bio/Pharma News

Vectalys, FlashCell Merge to Form Gene Therapy Company

The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.
/ read more /


Novartis' AveXis to Invest $55 Million in New Gene Therapy Manufacturing Facility

The gene therapy company is expected to invest $55 million in a new manufacturing facility that will produce therapies for rare neurological genetic diseases.
/ read more /


More Bio/Pharma News

Supplier News

University of Sheffield Opens Continuous OSD Pilot Plant

The UK's University of Sheffield opened a new chemical engineering teaching plant for continuous oral solid-dosage pharmaceuticals using GEA’s multipurpose platform.
/ read more /

 

FUJIFILM Adds Late-Phase and Commercial Fill/Finish Capabilities

In adding a Vanrx Pharmasystems aseptic filling isolator, FUJIFILM adds fill/finish for gene therapies and viral vaccines.
/ read more /


More Supplier News

FEATURED TOPICS

FILL/FINISH

Ready-to-Use Parenteral Packaging Components Address Evolving Aseptic Fill/Finish Requirements

Ready-to-use components eliminate the need for component preparation by the drug product manufacturer, enabling them to streamline their processes and focus on their core competencies, such as drug product development and manufacturing.
/ read more /

 

PEER-REVIEWED RESEARCH

Establishing Acceptance Limits for Uniformity of Dosage Units: Part 3

The working acceptance limits for acceptance values (AV) are determined using the critical values at, for example, 95% coverage over the corresponding AV distributions. However, validity of such limits needs to be elaborated.
/ read more /

MANUFACTURING

Aseptic Transfer Technology: Weighing Up the Advantages of Varying Approaches for Sterile Drug Manufacturing

Choosing the right contamination control platform requires considerable research into what a product needs for an effective process design.
/ read more /

ANALYTICS

Characterizing a Bioprocess with Advanced Data Analytics

Advanced data analytics tools are used by industry to find the golden nuggets in historical data, to aid in process development, to fine-tune production, and to achieve long-term improvements in product quality and throughput.
/ read more /


Product Profiles

Diosna Dierks & Söhne GmbH

Midilab RC
Midilab RC is Diosna's modular laboratory equipment that offers a fluid bed and a tablet coater module for a flexible production. Different batch sizes and a rapid change between the modules are just some of the benefits.
/ Read more/


LIVE WEBCAST

Continuous Processing in Biomanufacturing
Considerations for Adoption and Case Studies in Biologic Development and Manufacturing
Thursday, June 14, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
Register now


ON DEMAND WEBCASTS

The Pharma Supply Chain Revolution
On Demand
Learn more


How to Package Highly Complex Biologics
On Demand
Learn more


Events

ACHEMA 2018

Frankfurt am Main, Germany

11–15 June 2018

Chemspec Europe 2018

Koelnmesse, Cologne

20–21 June 2018

3rd PDA Europe Annual Meeting

Berlin, Germany

26–27 June 2018

SMi's 13th Annual ADMET Conference

London, United Kingdom

9–10 July 2018

16th International Conference and Exhibition on Pharmaceutical Formulations

Rome, Italy

26–27 July 2018


more events

eBOOKS

Biologics and Sterile Drug Manufacturing 2018

This ebook covers novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs, including single-use systems, facilities and equipment, contamination issues, and process analytics.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise